NM_001329128.2:c.-416A>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001329128.2(IFNGR2):c.-416A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 143,450 control chromosomes in the GnomAD database, including 5,891 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5889 hom., cov: 26)
Exomes 𝑓: 0.10 ( 2 hom. )
Consequence
IFNGR2
NM_001329128.2 5_prime_UTR
NM_001329128.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.45
Publications
8 publications found
Genes affected
IFNGR2 (HGNC:5440): (interferon gamma receptor 2) This gene (IFNGR2) encodes the non-ligand-binding beta chain of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. Defects in IFNGR2 are a cause of mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical mycobacterial infection. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance. [provided by RefSeq, Jul 2008]
IFNGR2 Gene-Disease associations (from GenCC):
- immunodeficiency 28Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 21-33403128-A-C is Benign according to our data. Variant chr21-33403128-A-C is described in ClinVar as Benign. ClinVar VariationId is 1232698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IFNGR2 | NM_001329128.2 | c.-416A>C | 5_prime_UTR_variant | Exon 1 of 8 | NP_001316057.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ENSG00000289939 | ENST00000701889.2 | n.*81A>C | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.249 AC: 35737AN: 143310Hom.: 5874 Cov.: 26 show subpopulations
GnomAD3 genomes
AF:
AC:
35737
AN:
143310
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.102 AC: 9AN: 88Hom.: 2 Cov.: 0 AF XY: 0.0938 AC XY: 6AN XY: 64 show subpopulations
GnomAD4 exome
AF:
AC:
9
AN:
88
Hom.:
Cov.:
0
AF XY:
AC XY:
6
AN XY:
64
show subpopulations
African (AFR)
AF:
AC:
3
AN:
4
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6
East Asian (EAS)
AF:
AC:
2
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
6
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
4
AN:
66
Other (OTH)
AF:
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.250 AC: 35777AN: 143362Hom.: 5889 Cov.: 26 AF XY: 0.252 AC XY: 17495AN XY: 69520 show subpopulations
GnomAD4 genome
AF:
AC:
35777
AN:
143362
Hom.:
Cov.:
26
AF XY:
AC XY:
17495
AN XY:
69520
show subpopulations
African (AFR)
AF:
AC:
18031
AN:
38992
American (AMR)
AF:
AC:
2640
AN:
14170
Ashkenazi Jewish (ASJ)
AF:
AC:
437
AN:
3308
East Asian (EAS)
AF:
AC:
2121
AN:
4956
South Asian (SAS)
AF:
AC:
1341
AN:
4516
European-Finnish (FIN)
AF:
AC:
1939
AN:
9294
Middle Eastern (MID)
AF:
AC:
35
AN:
280
European-Non Finnish (NFE)
AF:
AC:
8728
AN:
65006
Other (OTH)
AF:
AC:
409
AN:
1964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1167
2334
3501
4668
5835
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1204
AN:
3338
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.